Metastatic breast tumors, with high levels of CD44high/CD24low cells, display an up-regulation of binding immunoglobulin protein (BiP; a.k.a. GRP78, HSPA5) and protein disulfide isomerase (PDI) (Bartkowiak et al, 2010). Here, PDIA2 is linked to breast neoplasm.